Source: Arjun Walia

In Brief

  • The Facts:A new study has found that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon.
  • Reflect On:Should we be testing people for antibodies before giving them the vaccine?

An article written by Dr. Tamara Bhadari, a senior science writer from the Washington University School of Medicine in St. Louis, recently published an article explaining that even a mild COVID-19 infection induces lasting antibody protection that can last a lifetime. She sites a study recently published from researchers at Washington University School of Medicine in St. Louis showing that the protection gained from mild COVID-19 illness “leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon.”

Read More